Subscribe To Our Free Newsletter |
Glenmark Pharma enters into agreement with Celon Pharma; slips 2%
The company has entered into an agreement with Poland based Celon Pharma to develop and market a generic version of GlaxoSmithKline's Seretide Accuhaler in Europe used for treatment of lung diseases.